Ouafik L - Search Results

1

Simultaneous determination of cytosine arabinoside and its metabolite uracil arabinoside in human plasma by LC-MS/MS: Application to pharmacokinetics-pharmacogenetics pilot study in AML patients.

Donnette M, Solas C, Giocanti M, Venton G, Farnault L, Berda-Haddad Y, Hau LTT, Costello R, Ouafik L, Lacarelle B, Ciccolini J, Fanciullino R. Donnette M, et al. Among authors: ouafik l. J Chromatogr B Analyt Technol Biomed Life Sci. 2019 Sep 15;1126-1127:121770. doi: 10.1016/j.jchromb.2019.121770. Epub 2019 Aug 19. J Chromatogr B Analyt Technol Biomed Life Sci. 2019. PMID: 31454720

2

Letter to the editor: pharmacokinetics of gemcitabine in non-small-cell lung cancer patients: impact of the 79A>C cytidine deaminase polymorphism.

Mercier C, Dahan L, Ouafik L, André N, Ciccolini J. Mercier C, et al. Among authors: ouafik l. Eur J Clin Pharmacol. 2010 Sep;66(9):959-60. doi: 10.1007/s00228-010-0859-5. Epub 2010 Jun 19. Eur J Clin Pharmacol. 2010. PMID: 20563566 No abstract available.

3

Dahan L, Ciccolini J, Evrard A, Mbatchi L, Tibbitts J, Ries P, Norguet E, Mercier C, Iliadis A, Ouafik L, Lacarelle B, Seitz JF. Dahan L, et al. Among authors: ouafik l. J Clin Oncol. 2012 Feb 1;30(4):e41-4. doi: 10.1200/JCO.2011.37.9289. Epub 2011 Dec 19. J Clin Oncol. 2012. PMID: 22184401 No abstract available.

4

CDA deficiency as a possible culprit for life-threatening toxicities after cytarabine plus 6-mercaptopurine therapy: pharmacogenetic investigations.

Ciccolini J, Evrard A, M'Batchi L, Pourroy B, Mercier C, Iliadis A, Lacarelle B, Verschuur A, Ouafik L, André N. Ciccolini J, et al. Among authors: ouafik l. Pharmacogenomics. 2012 Mar;13(4):393-7. doi: 10.2217/pgs.11.175. Pharmacogenomics. 2012. PMID: 22379997

5

Rapid deaminator status is associated with poor clinical outcome in pancreatic cancer patients treated with a gemcitabine-based regimen.

Serdjebi C, Seitz JF, Ciccolini J, Duluc M, Norguet E, Fina F, Lacarelle B, Ouafik L, Dahan L. Serdjebi C, et al. Among authors: ouafik l. Pharmacogenomics. 2013 Jul;14(9):1047-51. doi: 10.2217/pgs.13.93. Pharmacogenomics. 2013. PMID: 23837479

6

Recipient/donor contradictory genotypes with impact on drug pharmacogenetics after liver transplant: a deadly gift?

Serdjebi C, Ciccolini J, Fina F, Delarue A, Verschuur A, Lacarelle B, Ouafik L, André N. Serdjebi C, et al. Among authors: ouafik l. Pharmacogenet Genomics. 2014 Oct;24(10):527-9. doi: 10.1097/FPC.0000000000000076. Pharmacogenet Genomics. 2014. PMID: 25003625

7

Lethal toxicity after administration of azacytidine: implication of the cytidine deaminase-deficiency syndrome.

Fanciullino R, Mercier C, Serdjebi C, Berda Y, Fina F, Ouafik L, Lacarelle B, Ciccolini J, Costello R. Fanciullino R, et al. Among authors: ouafik l. Pharmacogenet Genomics. 2015 Jun;25(6):317-21. doi: 10.1097/FPC.0000000000000139. Pharmacogenet Genomics. 2015. PMID: 25850965

8

Yin and yang of cytidine deaminase roles in clinical response to azacitidine in the elderly: a pharmacogenetics tale.

Fanciullino R, Mercier C, Serdjebi C, Venton G, Colle J, Fina F, Ouafik L, Lacarelle B, Ciccolini J, Costello R. Fanciullino R, et al. Among authors: ouafik l. Pharmacogenomics. 2015 Nov;16(17):1907-12. doi: 10.2217/pgs.15.135. Epub 2015 Nov 10. Pharmacogenomics. 2015. PMID: 26556583

9

CDA as a predictive marker for life-threatening toxicities in patients with AML treated with cytarabine.

Fanciullino R, Farnault L, Donnette M, Imbs DC, Roche C, Venton G, Berda-Haddad Y, Ivanov V, Ciccolini J, Ouafik L, Lacarelle B, Costello R. Fanciullino R, et al. Among authors: ouafik l. Blood Adv. 2018 Mar 13;2(5):462-469. doi: 10.1182/bloodadvances.2017014126. Blood Adv. 2018. PMID: 29490977 Free PMC article.

10

Lethal toxicities after capecitabine intake in a previously 5-FU-treated patient: why dose matters with dihydropryimidine dehydrogenase deficiency.

Gbeto CC, Quaranta S, Mari R, Fanciullino R, Roche C, Nahon S, Solas C, Ouafik L, Lacarelle B, Allegre T, Ciccolini J. Gbeto CC, et al. Among authors: ouafik l. Pharmacogenomics. 2019 Aug;20(13):931-938. doi: 10.2217/pgs-2019-0028. Pharmacogenomics. 2019. PMID: 31486738

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

165 results

Search Page

Filters